<DOC>
	<DOCNO>NCT01399086</DOCNO>
	<brief_summary>This retrospective chart-review study base collection data electronical paper-based medical record available data patient commence treatment fulvestrant January 1st 2007 . All necessary information purpose present study collect use paper-Case Record Form .</brief_summary>
	<brief_title>Fulvestrant Postmenopausal Patients With Metastatic Breast Cancer</brief_title>
	<detailed_description>To date , available data use fulvestrant treatment postmenopausal woman metastatic breast cancer current clinical practice Greece . In view significant lack knowledge , design retrospective study order evaluate effectiveness fulvestrant real-life setting , obtain data regard use fulvestrant current clinical practice among treat physician Greece . This retrospective study aim address following question : - What clinical outcome fulvestrant treatment term TTP use metastatic breast cancer real life clinical setting ? - What position fulvestrant hormone therapy sequence metastatic breast cancer Greece ? - What clinical outcome ( ORR , duration response , CBR ) fulvestrant treatment metastatic breast cancer real life clinical set relation clinical outcome fulvestrant 's position treatment sequence ? - What usual duration fulvestrant treatment metastatic breast cancer real life clinical setting reason treatment discontinuation ? - Treatment failure fulvestrant : next step sequence accord patient ' breast cancer treatment history ?</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Postmenopausal woman ERpositive and/or PgRpositive breast cancer fail least one prior endocrine therapy , either adjuvant treatment treatment advance disease Patients receive treatment fulvestrant metastatic breast cancer completed/discontinued treatment regardless outcome/reason discontinuation ( except treatment discontinuation nonclinical reason ) Patients postmenopausal status time treatment fulvestrant Patients currently undergo treatment fulvestrant Investigators/treating physician available electronical paperbased medical record</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Breast</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Hormonotherapy</keyword>
</DOC>